January 30, 2019
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Read More
January 30, 2019
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Read More
January 30, 2019
Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)
Read More
January 30, 2019
Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)
Read More
January 30, 2019
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen’s HBV Vaccine, or Fendrix™
Read More
January 30, 2019
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen’s HBV Vaccine, or Fendrix™
Read More
January 30, 2019
PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b
Read More
January 30, 2019
Telaprevir Open-Label Study in Co-Infected Patients
Read More
January 30, 2019
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Read More
January 30, 2019
A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6
Read More
January 30, 2019
A Study to Compare the Immune Response and Safety Elicited by Henogen’s Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
Read More
January 30, 2019
A Study to Compare the Immune Response and Safety Elicited by Henogen’s Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
Read More
Load More
X